Back to Search
MATTHEW GRANT, PHARMD
PHARMD
Pharmacist
NPI: 1073117610Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Erythropoietin: when liability becomes asset in neurovascular repair.
PMID 18219388·J Clin Invest·2008
7-preclinical
The potential role of octreotide in the treatment of diabetic retinopathy.
PMID 16053337·Treat Endocrinol·2005
6-review
The role of growth factors in the pathogenesis of diabetic retinopathy.
PMID 15461557·Expert Opin Investig Drugs·2004
6-review
The contribution of adult hematopoietic stem cells to retinal neovascularization.
PMID 12674209·Adv Exp Med Biol·2003
6-review
Somatostatin analogues as drug therapies for retinopathies.
PMID 12582462·Drugs Today (Barc)·2002
6-review
Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization.
PMID 12042812·Nat Med·2002
7-preclinical
Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.
PMID 11481274·Invest Ophthalmol Vis Sci·2001
8-other
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.
PMID 10857943·Diabetes Care·2000
3-trial
Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.
PMID 10892876·Invest Ophthalmol Vis Sci·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1390 S JEFFERSON ST
MONTICELLO, FL 32344 - Phone
- (850) 997-4108
Quick Facts
- NPI
- 1073117610
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile